VistaGen Therapeutics, Inc. (VTGN) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Vistagen Therapeutics (VTGN) fobiyalarga qarshi kurashish uchun burun sprey-larini ishlab chiqib, psixofarmakologiya bozorini egallamoqda. GURU.Markets platformasidagi uzoq muddatli kapital tuzilmasi ko'rsatkichi moliyaviy barqarorlikni namoyish etadi, bunda 0.00 ushbu metrikaning bazaviy darajasini aks ettiradi. Kompaniyaning daromadlari dorixonalar va sug'urta kompaniyalari orqali amalga oshirilgan sotuvlarga asoslangan. Ishlab chiqish jarayoni molekulalarni skrining qilish uchun AI modullari va robototexnika tizimlarining joriy etilishiga tayanadi.
&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_VTGN_-_Vistagen-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "VTGN - VistaGen Therapeutics Inc Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 01.11.2026 oraligʻida | 👁️GURU.Markets👁️")
VistaGen Therapeutics, Inc. (VTGN) kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Vistagen Therapeutics|VTGN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati VistaGen Therapeutics Inc|VTGN - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Vistagen Therapeutics|VTGN - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Vistagen|Oraliq likvidlik koeffitsiyenti vistagen.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:Vistagen Therapeutics
Ushbu ko'rsatkich Vistagen Therapeutics (VTGN) barqarorligini uzoq muddatli majburiyatlarning bozor qiymatiga nisbatiga qarab baholaydi. Kapital tuzilmasidagi uzoq muddatli kreditlar ulushini tahlil qilish orqali investor emitentning tashqi qarzga bog'liqlik darajasini aniqlaydi. Vistagen Therapeutics (VTGN) uchun bu burun sprey-lari ishlab chiqilishini moliyalashtirishda juda muhimdir. Qarz yuklamasining pastligi dori vositalarini bozorga chiqarishda moliyaviy moslashuvchanlikni tasdiqlaydi. Ushbu ko'rsatkich investitsiya xavfsizligining indikatori bo'lib xizmat qiladi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati DNLI|Uzoq muddatli qarzning o'z kapitaliga nisbati HRMY|Uzoq muddatli qarzning kapitalga nisbati BHVN|Uzoq muddatli qarzdorlikning kapitalga nisbati Amylyx Pharmaceuticals Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|Uzoq muddatli qarzdorlikning kapitalga nisbati Praxis Corp (PRAX)|AVXL: Uzoq muddatli qarzning o'z kapitaliga nisbati|ceribell.com - Uzoq muddatli kreditlarning kapitalga nisbati|PRTA: Uzoq muddatli qarzning kapitalga nisbati|Alector (ALEC) - Uzoq muddatli qarzning kapitalga nisbati|ANNX (Annexon Inc.) - Uzoq muddatli qarzning kapitalga nisbati|OMER - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati NGNE|ACIU - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Voyager Therapeutics, Inc. VYGR|NMRA: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|SCLX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TVGN (Tevogen Bio Inc.)|ACOG (alphacognition.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CGTX: Uzoq muddatli kreditlarning kapitalga nisbati|IKT (Inhibikase Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|SAVA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ASRT|COYA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Ovid Therapeutics OVID|Uzoq muddatli qarzning kapitalga koeffitsiyenti ABOS|CervoMed - Uzoq muddatli qarzning kapitalga nisbati|ATHE - Uzoq muddatli qarzning kapitalga nisbati|clene.com (CLNN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati PEPG (PepGen)|JUNS (Jupiter Neurosciences Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati relmada.com RLMD|Uzoq muddatli qarzning o'z kapitaliga nisbati ANVS (Annovis Bio)|Uzoq muddatli qarzning kapitalga nisbati gracetx.com (GRCE)|Firefly Neuroscience Inc - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati KLTO (ANEW Medical)|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati revivapharma.com RVPH|MTVA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeurAxis Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Passage Bio Corp (PASG) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NEUP (Neuphoria Therapeutics Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati NERV (minervaneurosciences.com)|Athira Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati ADXN (Addex Therapeutics Ltd.)|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Cyclerion Therapeutics (CYCN)|protagenic.com (PTIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi KTTA|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXI (Avenue Therapeutics Inc.)|Uzoq muddatli qarzning kapitalga nisbati BCLI|CARA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Chromocell Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Eliem Therapeutics, Inc. ELYM|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti LBPH (Longboard Pharmaceuticals Inc)|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NKGen Biotech Corp (NKGN)|Uzoq muddatli qarzning o'z kapitaliga nisbati NRBO|Uzoq muddatli qarzning o'z kapitaliga nisbati SAGE|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzdorlikning kapitalga nisbati Trevena Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|Uzoq muddatli qarzdorlikning kapitalga nisbati Anew Medical Inc. (WENA)|CERE: Uzoq muddatli qarzning o'z kapitaliga nisbati